Molecular modeling of mammalian cytochrome P450s

Cellular and Molecular Life Sciences

Volumn 57, Issue 3, 2000, Pages 487-499

  Dai, R ^a   Pincus, M R ^b,c   Friedman, F K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Cytochrome P450; Drug metabolism; Molecular modeling; Protein structure

Indexed keywords

BACTERIAL PROTEIN; CYTOCHROME P450;

DRUG METABOLISM; MOLECULAR MODEL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN STRUCTURE; REVIEW; XENOBIOTIC METABOLISM;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0010621578     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000709     Document Type: Review

References (63)

1. 1 Ortiz de Montellano P. (1995) Cytochrome P450 Structure, Mechanism, and Biochemistry, 2nd edn, Plenum, New York
2. 2 Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J. et al. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6: 1-42
3. 3 Poulos T. L., Finzel B. C. and Howard A. J. (1987) High-resolution crystal structure of cytochrome P450cam. J. Mol. Biol. 195: 687-700
4. 4 Ravichandran K. G., Boddupalli S. S., Hasermann C. A., Peterson J. A. and Deisenhofer J. (1993) Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science 261: 731-736
5. 5 Hasemann C. A., Ravichandran K. G., Peterson J. A. and Deisenhofer J. (1994) Crystal structure and refinement of cytochrome P450terp at 2.3 Å resolution. J. Mol. Biol. 236: 1169-1185
6. 6 Cupp-Vickery J. R. and Poulos T. L. (1995) Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nat. Struct. Biol. 2: 144-153
7. 7 Nelson D. R. and Strobel H. W. (1988) On the membrane topology of vertebrate cytochrome P-450 proteins. J. Biol. Chem. 263: 6038-6050
8. 8 Nelson D. R. and Strobel H. W. (1989) Secondary structure prediction of 52 membrane-bound cytochromes P450 shows a strong structural similarity to P450cam. Biochemistry 28: 656-660
9. 9 Edwards R. J., Murray B. P., Boobis A. R. and Davies D. S. (1989) Identification and location of alpha-helices in mammalian cytochromes P450. Biochemistry 28: 3762-3770
10. 10 Gotoh O. (1992) Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J. Biol. Chem. 267: 83-90
11. 11 Lewis D. F. and Moereels H. (1992) The sequence homologies of cytochromes P-450 and active-site geometries. J. Comput. Aided. Mol. Des. 6: 235-252
12. 12 Korzekwa K. R. and Jones J. P. (1993) Predicting the cytochrome P450 mediated metabolism of xenobiotics. Pharmacogenetics 3: 1-18
13. 13 Lewis D. F. (1995) Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450BM3). Xenobiotica 25: 333-366
14. 14 Hasemann C. A., Kurumbail R. G., Boddupalli S. S., Peterson J. A. and Deisenhofer J. (1995) Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure 3: 41-62
15. 15 Ferenczy G. G. and Morris G. M. (1989) The active-site of cytochrome P-450 nifedipine oxidase a model-building study. J. Mol. Graph. 7: 206-211
16. 16 Lewis, D. F. V. (1996) Molecular modeling of mammalian cytochromes P450. In: Cytochromes P450: Metabolic and Toxicological Aspects, pp. 355-398, Iounnides C. (ed.), CRC, Boca Raton
17. 17 Szklarz G. D. and Halpert J. R. (1997) Use of homology modeling in conjunction with site-directed mutagenesis for analysis of structure-function relationships of mammalian cytochromes P450. Life Sci. 61: 2507-2520
18. 18 Groot M. J. de and Vermeulen N. P. (1997) Modeling the active sites of cytochrome P450s and glutathione S-transferases, two of the most important biotransformation enzymes. Drug Metab. Rev. 29: 747-799
19. 19 Peterson J. A. and Graham S. E. (1998) A close family resemblance: the importance of structure in understanding cytochromes P450. Structure 6: 1079-1085
20. 20 Nelson D. R. (1998) Metazoan cytochrome P450 evolution. Comp. Bioehem. Physiol. C Pharmacol. Toxicol. Endocrinol. 121: 15-22
21. 21 Jean P., Pothier J., Dansette P. M., Mansuy D. and Viari A. (1997) Automated multiple analysis of protein structures: application to homology modeling of cytochromes P450. Proteins 28: 388-404
22. 22 Li H. and Poulos T. L. (1997) The structure of the cytochrome P450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nat. Struct. Biol. 4: 140-146
23. 23 Lewis D. F. (1998) The CYP2 family: models, mutants and interactions. Xenobiotica 28: 617-661
24. 24 Lewis D. F. and Lake B. G. (1996) Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: rationalization of CYP1A substrate specificity in terms of active site amino acid residues. Xenobiotica 26: 723-753
25. 25 Dai R., Zhui S., Wei X., Pincus M. R., Vestal R. E. and Friedman F. K. (1998) Inhibition of human cytochrome P450 IA2 by flavones: a molecular modeling study. J. Protein Chem. 17: 643-650
26. 26 Lewis D. F. V., Dickens M., Lake B. G., Eddershaw P. J., Tarbit M. H. and Goldfarb P. S. (1999) Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity. Toxicology 133: 1-33
27. 27 Lewis D. F. and Lake B. G. (1997) Molecular modelling of mammalian CYP2B isoforms and their interaction with substrates, inhibitors and redox partners. Xenobiotica 27: 443-478
28. 28 Dai R., Pincus M. R. and Friedman F. K. (1998) Molecular modeling of cytochrome P450 2B1: mode of membrane insertion and substrate specificity. J. Protein Chem. 17: 121-129
29. 5 binding site and comparisons with CYP2B1 and CYP2B4. Xenobiotica 29: 361-393
30. 30 Lewis D. F., Bird M. G. and Parke D. V. (1997) Molecular modelling of CYP2E1 enzymes from rat, mouse and man: an explanation for species differences in butadiene metabolism and potential carcinogenicity, and rationalization of CYP2E substrate specificity. Toxicology 118: 93-113
31. 31 Tan Y., White S. P., Paranawithana S. R. and Yang C. S. (1997) A hypothetical model for the active site of human cytochrome P4502E1. Xenobiotica 27: 287-299
32. 32 Lewis D. F., Eddershaw P. J., Goldfarb P. S. and Tarbit M. H. (1996) Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals. Xenobiotica 26: 1067-1086
33. 33 Lewis D. F. V. and Lake B. G. (1999) Molecular modelling of CYT4A subfamily members based on sequence homology with CYP102. Xenobiotica 29: 763-781
34. 34 Burke D. F., Laughton C. A. and Neidle S. (1997) Homology modelling of the enzyme P450 17 alpha-hydroxylase/17,20-lyase - a target for prostate cancer chemotherapy from the crystal structure of P450BM-3. Anticancer Drug Des. 12: 113-123
35. 35 Shyue S. K., Ruan K. H., Wang L. H. and Wu K. K. (1997) Prostacyclin synthase active sites: identification by molecular modeling-guided site-directed mutagenesis. J. Biol. Chem. 272: 3657-3662
36. 36 Ruan K. H., Milfeld K., Kulmacz R. J. and Wu K. K. (1994) Comparison of the construction of a 3-D model for human thromboxane synthase using P450cam and BM-3 as templates implications for the substrate-binding pocket. Protein Eng. 7: 1345-1351
37. 37 Graham-Lorence S., Amarneh B., White R. E., Peterson J. A. and Simpson E. R. (1995) A three-dimensional model of aromatase cytochrome P450. Protein Sci. 4: 1065-1080
38. 38 Groot M. J. de, Vermeulen N. P., Kramer J. D., Acker F. A. van and Donne-Op d. K. G. (1996) A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108. Chem. Res. Toxicol. 9: 1079-1091
39. 39 Szklarz G. D., He Y. A. and Halpert J. R. (1995) Site-directed mutagenesis as a tool for molecular modeling of cytochrome P450 2B1. Biochemistry 34: 14312-14322
40. 40 Lewis D. F. and Lake B. G. (1995) Molecular modelling of members of the P4502A subfamily: application to studies of enzyme specificity. Xenobiotica 25: 585-598
41. 41 Rost B. and Sander C. (1993) Prediction of protein secondary-structure at better than 70-percent accuracy. J. Mol. Biol. 232: 584-599
42. 42 Rost B. and Sander C. (1994) Combining evolutionary information and neural networks to predict protein secondary structure. Prot. Struct. Funct. Genet. 19: 55-72
43. 43 Szklarz G. D., Ornstein R. L. and Halpert J. R. (1994) Application of 3-dimensional homology modeling of cytochrome P450 2B1 for interpretation of site-directed mutagenesis results. J. Biomol. Struct. Dyn. 12: 61-78
44. 44 Szklarz G. D. and Halpert J. R. (1997) Molecular modeling of cytochrome P450 3A4. J. Comput. Aided Mol. Des. 11: 265-272
45. 45 Chang Y. T., Stiffelman O. B., Vakser I. A., Loew G. H., Bridges A. and Waskell L. (1997) Construction of a 3D model of cytochrome P450 2B4. Protein Eng. 10: 119-129
46. 46 Chang Y. T. and Loew G. H. (1999) Homology modeling and substrate binding study of human CYP4A11 enzyme. Proteins 34: 403-415
47. 47 Przytycka T., Aurora R. and Rose G. D. (1999) A protein taxonomy based on secondary structure. Nat. Struct. Biol. 6: 672-682
48. 48 Koley A. P., Robinson R. C. and Friedman F. K. (1996) Cytochrome P450 conformation and substrate interactions as probed by CO binding kinetics. Biochimie 78: 706-713
49. 49 Frauenfelder H. (1997) The complexity of proteins. In: Physics of Biological Systems: from Molecules to Species, pp. 29-60, Flyvbjerg H., Hertz J., Jensen M. H., Mouritsen O. G. and Snepper K. (eds), Springer, Berlin
50. 50 Ruan K. H., Li D. W., Ji J., Lin Y. Z. and Gao X. L. (1998) Structural characterization and topology of the second potential membrane anchor region in the thromboxane A(2) synthase amino-terminal domain. Biochemistry 37: 822-830
51. 51 Miller J. P., Herbette L. G. and White R. E. (1996) X-ray diffraction analysis of cytochrome P450 2B4 reconstituted into liposomes. Biochemistry 35: 1466-1474
52. 52 Shank-Retzlaff M. L., Raner G. M., Coon M. J. and Sugar S. G. (1998) Membrane topology of cytochrome P450 2B4 in Langmuir-Blodgett monolayers. Arch. Biochem. Biophys. 359: 82-88
53. 53 Modi S., Sutcliffe M. J., Primrose W. U., Lian L. Y. and Roberts G. C. (1996) The catalytic mechanism of cytochrome P450 BM3 involves a 6 A movement of the bound substrate on reduction. Nat. Struct. Biol. 3: 414-417
54. 54 Lee H., Montellano P. R. O. de and McDermott A. E. (1999) Deuterium magic angle spinning studies of substrates bound to cytochrome P450. Biochemistry 38: 10808-10813
55. 55 Parikh A., Josephy P. D. and Guengerich F. P. (1999) Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties. Biochemistry 38: 5283-5289
56. 56 Yun C. H., Hammons G. J., Jones G., Martin M. V., Hopkins N. E., Alworth W. L. et al. (1992) Modification of cytochrome-P450 1A2 enzymes by the mechanism-based inactivator 2-ethynylnaphthalene and the photoaffinity label 4-azidobiphenyl. Biochemistry 31: 10556-10563
57. 57 Modi S., Paine M. J., Sutcliffe M. J., Lian L. Y., Primrose W. U., Wolf C. R. et al. (1996) A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding. Biochemistry 35: 4540-4550
58. 5: inhibition by synthetic peptides indicates a role for P450 residues Lys-122 and Arg-125. Biochem. Biophys. Res. Commun. 201: 1090-1095
59. 59 DeVoss J. J., Sibbesen O., Zhang Z. P. and deMontellano P. R. O. (1997) Substrate docking algorithms and prediction of the substrate specificity of cytochrome P450(cam) and its L244A mutant. J. Am. Chem. Soc. 119: 5489-5498
60. 60 Ekins S., Bravi G., Binkley S., Gillespie J. S., Ring B. J., Wikel J. H. et al. (1999) Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors. Pharmacogenetics 9: 477-489
61. 61 Ekins S., Bravi G., Binkley S., Gillespie J. S., Ring B. J., Wikel J. H. et al. (1999) Three-and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors. J. Pharmacol. Exp. Ther. 290: 429-438
62. 62 Groot M. J. de, Ackland M. J., Home V. A., Alex A. A. and Jones B. C. (1999) Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6. J. Med. Chem. 42: 1515-1524
63. 63 Groot M. J. de, Ackland M. J., Horne V. A., Alex A. A. and Jones B. C. (1999) A novel approach to predicting P450 mediated drug metabolism: CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6. J. Med. Chem. 42: 4062-4070